Literature DB >> 28711148

A Review of Systemic Corticosteroid Use in Pregnancy and the Risk of Select Pregnancy and Birth Outcomes.

Gretchen Bandoli1, Kristin Palmsten2, Chelsey J Forbess Smith3, Christina D Chambers2.   

Abstract

The evidence to date regarding corticosteroid exposure in pregnancy and select pregnancy and birth outcomes is limited and inconsistent. The authors provide a narrative review of published literature summarizing the findings for oral clefts, preterm birth, birth weight, preeclampsia, and gestational diabetes mellitus. Whenever possible, the results are limited to oral or systemic administration with a further focus on use in autoimmune disease. Although previous studies of corticosteroid exposure in pregnancy reported an increased risk of oral clefts in the offspring, more recent studies have not replicated these findings.
Copyright © 2017 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Adverse pregnancy and birth outcomes; Corticosteroids; Pregnancy; Review

Mesh:

Substances:

Year:  2017        PMID: 28711148      PMCID: PMC5604866          DOI: 10.1016/j.rdc.2017.04.013

Source DB:  PubMed          Journal:  Rheum Dis Clin North Am        ISSN: 0889-857X            Impact factor:   2.670


  48 in total

1.  Birth defects after maternal exposure to corticosteroids: prospective cohort study and meta-analysis of epidemiological studies.

Authors:  L Park-Wyllie; P Mazzotta; A Pastuszak; M E Moretti; L Beique; L Hunnisett; M H Friesen; S Jacobson; S Kasapinovic; D Chang; O Diav-Citrin; D Chitayat; I Nulman; T R Einarson; G Koren
Journal:  Teratology       Date:  2000-12

Review 2.  Corticosteroids, pregnancy, and HELLP syndrome: a review.

Authors:  P J van Runnard Heimel; A Franx; A F A M Schobben; A J M Huisjes; J B Derks; H W Bruinse
Journal:  Obstet Gynecol Surv       Date:  2005-01       Impact factor: 2.347

3.  Production of congenital defects in the off-spring of pregnant mice treated with cortisone; progress report.

Authors:  F C FRASER; T D FAINSTAT
Journal:  Pediatrics       Date:  1951-10       Impact factor: 7.124

4.  Factors that predict prematurity and preeclampsia in pregnancies that are complicated by systemic lupus erythematosus.

Authors:  Eliza F Chakravarty; Iris Colón; Elizabeth S Langen; David A Nix; Yasser Y El-Sayed; Mark C Genovese; Maurice L Druzin
Journal:  Am J Obstet Gynecol       Date:  2005-06       Impact factor: 8.661

Review 5.  Safety and efficacy of fluticasone propionate in the topical treatment of skin diseases.

Authors:  A Roeder; M Schaller; M Schäfer-Korting; H C Korting
Journal:  Skin Pharmacol Physiol       Date:  2005 Jan-Feb       Impact factor: 3.479

6.  Maternal corticosteroid use and risk of selected congenital anomalies.

Authors:  S L Carmichael; G M Shaw
Journal:  Am J Med Genet       Date:  1999-09-17

Review 7.  Steroid use during pregnancy.

Authors:  Deborah Cooper McGee
Journal:  J Perinat Neonatal Nurs       Date:  2002-09       Impact factor: 1.638

8.  Effects of fluticasone propionate, triamcinolone acetonide, prednisone, and placebo on the hypothalamic-pituitary-adrenal axis.

Authors:  J T Li; M F Goldstein; G N Gross; M J Noonan; S Weisberg; L Edwards; K D Reed; P R Rogenes
Journal:  J Allergy Clin Immunol       Date:  1999-04       Impact factor: 10.793

9.  Pregnancy outcome after first trimester exposure to corticosteroids: a prospective controlled study.

Authors:  Chamutal Gur; Orna Diav-Citrin; Svetlana Shechtman; Judy Arnon; Asher Ornoy
Journal:  Reprod Toxicol       Date:  2004 Jan-Feb       Impact factor: 3.143

10.  First trimester exposure to corticosteroids and oral clefts.

Authors:  Pierre Pradat; Elisabeth Robert-Gnansia; Gian Luca Di Tanna; Aldo Rosano; Alessandra Lisi; Pierpaolo Mastroiacovo
Journal:  Birth Defects Res A Clin Mol Teratol       Date:  2003-12
View more
  37 in total

Review 1.  Glucocorticoids in pregnancy.

Authors:  Riccardo Pofi; Jeremy W Tomlinson
Journal:  Obstet Med       Date:  2019-06-09

2.  Gestational and Postpartum Weight Trajectories Among Women With and Without Asthma.

Authors:  Danielle R Stevens; William Grobman; Rajesh Kumar; Leah M Lipsky; Stefanie N Hinkle; Zhen Chen; Andrew Williams; Matthew C H Rohn; Jenna Kanner; Seth Sherman; Pauline Mendola
Journal:  Am J Epidemiol       Date:  2021-05-04       Impact factor: 4.897

3.  Approach to evaluating pregnancy safety of anti-rheumatic medications in the OTIS MotherToBaby pregnancy studies: what have we learned?

Authors:  Christina Chambers; Diana L Johnson; Elizabeth Kiernan
Journal:  Rheumatology (Oxford)       Date:  2018-07-01       Impact factor: 7.580

4.  Factors Associated With Preterm Delivery Among Women With Rheumatoid Arthritis and Women With Juvenile Idiopathic Arthritis.

Authors:  Chelsey J F Smith; Frauke Förger; Gretchen Bandoli; Christina D Chambers
Journal:  Arthritis Care Res (Hoboken)       Date:  2019-07-04       Impact factor: 4.794

5.  Machine learning on drug-specific data to predict small molecule teratogenicity.

Authors:  Anup P Challa; Andrew L Beam; Min Shen; Tyler Peryea; Robert R Lavieri; Ethan S Lippmann; David M Aronoff
Journal:  Reprod Toxicol       Date:  2020-05-16       Impact factor: 3.143

6.  Oral corticosteroid use during pregnancy and risk of preterm birth.

Authors:  Kristin Palmsten; Gretchen Bandoli; Gabriela Vazquez-Benitez; Min Xi; Diana L Johnson; Ronghui Xu; Christina D Chambers
Journal:  Rheumatology (Oxford)       Date:  2020-06-01       Impact factor: 7.580

7.  Patterns of prednisone use during pregnancy in women with rheumatoid arthritis: Daily and cumulative dose.

Authors:  Kristin Palmsten; Matthieu Rolland; Mary F Hebert; Megan E B Clowse; Michael Schatz; Ronghui Xu; Christina D Chambers
Journal:  Pharmacoepidemiol Drug Saf       Date:  2018-02-28       Impact factor: 2.890

Review 8.  Management of Inflammatory Bowel Diseases in Special Populations: Obese, Old, or Obstetric.

Authors:  Siddharth Singh; Sherman Picardo; Cynthia H Seow
Journal:  Clin Gastroenterol Hepatol       Date:  2019-11-08       Impact factor: 11.382

Review 9.  Neuromyelitis optica spectrum disorders and pregnancy: therapeutic considerations.

Authors:  Yang Mao-Draayer; Sandra Thiel; Elizabeth A Mills; Tanuja Chitnis; Michelle Fabian; Ilana Katz Sand; M Isabel Leite; Sven Jarius; Kerstin Hellwig
Journal:  Nat Rev Neurol       Date:  2020-02-20       Impact factor: 42.937

10.  Oral Corticosteroids and Risk of Preterm Birth in the California Medicaid Program.

Authors:  Kristin Palmsten; Gretchen Bandoli; Jim Watkins; Gabriela Vazquez-Benitez; Todd P Gilmer; Christina D Chambers
Journal:  J Allergy Clin Immunol Pract       Date:  2020-08-11
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.